Abstract
The melanin-concentrating hormone receptor 1 (MCH-1R) has been recognized as a receptor which mediates effects of the endogenous melanin-concentrating hormone (MCH) on appetite and body weight gain in rodents. In the last several years, a number of hMCH analogs have been designed which were potent and selective ligands for hMCH-1R. These peptidic agonists and antagonists have served as research tools in animal studies that showed a key role of the MCH-1R in the development of obesity and proved that MCH-1R antagonism can produce anti-obesity effects in rodents.
Keywords: Melanin-concentrating hormone, melanin-concentrating hormone receptor, antagonist, obesity
Current Topics in Medicinal Chemistry
Title: Peptide Ligands for the Melanin-Concentrating Hormone (MCH) Receptor 1
Volume: 7 Issue: 15
Author(s): Maria A. Bednarek
Affiliation:
Keywords: Melanin-concentrating hormone, melanin-concentrating hormone receptor, antagonist, obesity
Abstract: The melanin-concentrating hormone receptor 1 (MCH-1R) has been recognized as a receptor which mediates effects of the endogenous melanin-concentrating hormone (MCH) on appetite and body weight gain in rodents. In the last several years, a number of hMCH analogs have been designed which were potent and selective ligands for hMCH-1R. These peptidic agonists and antagonists have served as research tools in animal studies that showed a key role of the MCH-1R in the development of obesity and proved that MCH-1R antagonism can produce anti-obesity effects in rodents.
Export Options
About this article
Cite this article as:
Bednarek A. Maria, Peptide Ligands for the Melanin-Concentrating Hormone (MCH) Receptor 1, Current Topics in Medicinal Chemistry 2007; 7 (15) . https://dx.doi.org/10.2174/156802607782194734
DOI https://dx.doi.org/10.2174/156802607782194734 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Medicinal Chemistry Advancement in Life-Threatening Diseases
The current issue will highlight concise reports that specify ground-breaking insights, including the novel discovery of drug targets and their action mechanism or drugs of novel classes. These are projected to encourage medicinal chemistry future efforts to address the most challenging medical needs. The current issue highlights further efforts to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances in Azo Dye Degrading Enzyme Research
Current Protein & Peptide Science Dual Inhibitors of Monoamine Oxidase and Cholinesterase for the Treatment of Alzheimer Disease
Current Topics in Medicinal Chemistry Correlation Between DTI Findings and Volume of Corpus Callosum in Children with AUTISM
Current Medical Imaging Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous
Current Cancer Drug Targets Meet Our Editorial Board Member
Current Alzheimer Research The Possibilities and Pitfalls for Anti-Complement Therapies in Inflammatory Diseases
Current Drug Targets - Inflammation & Allergy New Targets for Therapy in Polyglutamine (polyQ) Expansion Diseases
Current Drug Therapy The Importance of Nicotinic Acetylcholine Receptors in Schizophrenia, Bipolar Disorder and Tourettes Syndrome
Current Drug Targets - CNS & Neurological Disorders CD6 as a Cell Surface Receptor and As a Target for Regulating Immune Responses
Current Drug Targets Mouse Models of Primary Sjogren’s Syndrome
Current Pharmaceutical Design When Neighbors Talk: Colon Cancer Cell Invasion and Tumor Microenvironment Myofibroblasts
Current Drug Targets Macrophages: Promising Targets for the Treatment of Atherosclerosis
Current Vascular Pharmacology Folate-modified Graphene Oxide as the Drug Delivery System to Load Temozolomide
Current Pharmaceutical Biotechnology Paeonol, a Powerful Natural Product with Broad Biological Spectra by Inhibiting Inflammatory Pathway
Current Traditional Medicine Anti-Aggressive, Brain Neurotransmitters and Receptor Binding Study of Fumaria indica in Rodents
Current Psychopharmacology Potassium Channels in Peripheral Pain Pathways: Expression, Function and Therapeutic Potential
Current Neuropharmacology The Mitochondrial Free Radical Theory of Aging: A Critical View
Current Aging Science Pelvic Floor Muscle Training During Pregnancy and After Delivery
Current Women`s Health Reviews A Novel Approach to Refractory Epilepsy by Targeting Pgp Peripherally and Centrally: Therapeutic Targets and Future Perspectives
CNS & Neurological Disorders - Drug Targets Aspects of Matrix Effects in Applications of Liquid Chromatography-Mass Spectrometry to Catecholamine Analysis-A Review
Current Analytical Chemistry